We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




US Administration Plans on Mapping the Human Brain

By LabMedica International staff writers
Posted on 11 Mar 2013
Print article
The Obama administration is planning a major scientific initiative, the mapping the human brain, to understand how it functions and malfunctions.

The initiative, dubbed the Brain Activity Map (BAM), will seek to map each of the approximately 100 billion neurons in the human brain, although initial studies will be performed in mice and other animals. The proposal for the project will be delivered to the US Congress as part of the president's budget package, and will carry a price tag of roughly USD 300 million a year over 10 years, totaling USD 3 billion. The effort is designed to be a collaboration between several federal agencies, including the National Institutes of Health (NIH; Bethesda, MD, USA), the National Science Foundation (NSF; Arlington, VA, USA), and private organizations.

News reports about the initiative indicated that a 2012 scientific commentary outlined experimental plans for the project, including a variety of specific experimental techniques that might be used to achieve what is termed as the functional connectome, as well as new technologies that will have to be developed in the course of the project. Initial studies might be done in Caenorhabditis elegans, followed by Drosophila, because of their comparatively simple neural circuits. Mid-term studies could be done in zebrafish, mice, and the Etruscan shrew, with studies ultimately to be done in primates and humans.

The project involves the development of nanoparticles that could be used as voltage sensors that would detect individual action potentials, as well as nanoprobes serving as electrophysiological multielectrode arrays. Other methods could use wireless, noninvasive methods of neuronal activity detection such as microelectronic very-large-scale integration and synthetic biology, rather than microelectronics. A related technique proposed the use of high-throughput DNA sequencing for rapidly mapping neural connectivity. The data would be analyzed and modeled by large scale computation. A description of the BAM project and the challenges it faces was published on February 22, 2013, in Neuron.

“To succeed, the BAM Project needs two critical components: strong leadership from funding agencies and scientific administrators, and the recruitment of a large coalition of interdisciplinary scientists,” concluded report coauthor Paul Alivisato, PhD, director of the Lawrence Berkeley National Laboratory (Berkeley, CA, USA), and colleagues. “We believe that neuroscience is ready for a large-scale functional mapping of the entire brain circuitry, and that such mapping will directly address the emergent level of function, shining much-needed light into the ‘impenetrable jungles’ of the brain.”

Related Links:

National Institutes of Health
National Science Foundation
Lawrence Berkeley National Laboratory


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.